11.5.2017 01:34 | Nasdaq OMX
Nasdaq Stockholders Elect Members to Board of Directors
New Director, Melissa M. Arnoldi, Elected to the Board and Eight Directors Re-Elected
Nasdaq Board Elects Michael R. Splinter as Chairman of the Board
NEW YORK, May 11, 2017 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq:NDAQ) stockholders today elected all nominated directors at the Annual Meeting of Stockholders. All directors will serve one-year terms. Elected board members include:
- Melissa M. Arnoldi, President of Technology Development, AT&T
- Charlene T. Begley, Former SVP & CIO, General Electric Company
- Steven D. Black, Co-CEO, Bregal Investments
- Adena T. Friedman, President and CEO, Nasdaq
- Glenn H. Hutchins, Co-Founder, Silver Lake
- Essa Kazim, Governor, Dubai International Financial Center and Chairman, Borse Dubai and Dubai Financial Market
- Thomas A. Kloet, Former CEO & Executive Director, TMX Group Limited
- Michael R. Splinter, Former Chairman and CEO, Applied Materials, Inc.
- Lars R. Wedenborn, CEO, FAM AB
Nasdaq stockholders also approved the following proposals:
- The company's executive compensation on an advisory basis;
- An advisory vote to conduct future advisory votes on the company's executive compensation every year; and
- Ratification of the appointment of Ernst & Young LLP as Nasdaq's independent registered public accounting firm for the fiscal year ending December 31, 2017.
The stockholders did not approve a stockholder proposal relating to the right to act by written consent.
The Nasdaq Board of Directors today elected Michael R. Splinter as Chairman of the Board.
About Michael R. Splinter:
Chairman Splinter has served on the Nasdaq Board since 2008. He is currently a business and technology consultant. Chairman Splinter served as Executive Chairman of the Board of Applied Materials, a Nasdaq listed company, from 2009 to his retirement in 2015 and was CEO from 2003 to 2013. An engineer and technologist, Chairman Splinter is a 40-year veteran of the semiconductor industry. Prior to joining Applied Materials, he was an executive at Intel Corporation for 20 years. Chairman Splinter was elected to the National Academy of Engineers in 2017.
About Melissa M. Arnoldi:
Ms. Arnoldi has been President of Technology Development at AT&T, a telecommunications company, since September 2016. Ms. Arnoldi has served in various capacities at AT&T since 2008 including: Senior Vice President, Technology Solutions & Business Strategy, from December 2014 to September 2016; Vice President, IT Strategy & Business Integration, from December 2012 to December 2014; and Assistant Vice President, IT from January 2008 to December 2012. Prior to AT&T, Ms. Arnoldi was a partner in the Communications & High Technology Industry Group at Accenture Ltd. from 2006-2008 serving in various other capacities from 1996-2008.
For additional biographical information on Nasdaq's board members, see the Nasdaq 2017 Proxy Statement .
Nasdaq (Nasdaq:NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 89 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to 3,800 total listings with a market value of $11 trillion. To learn more, visit: http://business.nasdaq.com
212 231 5534
646 441 5121
Information om Nasdaq OMX
Følg pressemeddelelser fra Nasdaq OMX
Ved at skrive dig op her, vil du modtage pressemeddelelser på mail når de udsendes. Indtast din mail og følg instruktionerne. Det er ligeså let at melde sig fra igen.
Flere pressemeddelelser fra Nasdaq OMX
Tetraphase Pharmaceuticals17.8.2017 14:31 | pressemeddelelse
Tetraphase Pharmaceuticals Announces Submission and Validation of IV Eravacycline Marketing Authorization Application by European Medicines Agency
RedHill Biopharma Ltd.17.8.2017 13:01 | pressemeddelelse
RedHill Biopharma Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium Delayed-Release Capsules
Safway Group16.8.2017 19:41 | pressemeddelelse
Brand Industrial Services Announces Agreement to Acquire Venko Groep BV
Abeona Therapeutics Inc16.8.2017 15:39 | pressemeddelelse
Abeona Therapeutics Announces Pivotal Expansion of ABO-102 Gene Therapy Clinical Trials in Sanfilippo Syndrome Type A
Callidus Software16.8.2017 14:02 | pressemeddelelse
CallidusCloud Wins Eight Gold Stevies® in the 2017 International Business Awards
Ascom Holding AG16.8.2017 08:02 | pressemeddelelse
Ascom Myco and Koutio Médipôle optimize care communications and responsiveness
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum